Evidence map›Paper›PMID 42083742›Full record

ReviewEssays in biochemistry2026

How social is social resistance?

Rosie Randall, Ashleigh S Griffin

Abstract readReview
In one paragraph

Review in Essays in biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rosie RandallDepartment of Biology, University of Oxford, South Parks Road, OX1 3EL, Oxford, U.K.
Ashleigh S GriffinDepartment of Biology, University of Oxford, South Parks Road, OX1 3EL, Oxford, U.K.ORCID 0000-0001-7674-9825

Funding

EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) 647586UKRI | Biotechnology and Biological Sciences Research Council (AFRC) N/A
6 · The paper itself

Abstract

β-lactamases are central to bacterial resistance against β-lactam antibiotics and are often treated as a textbook example of cooperative resistance. The cooperative aspect of their action arises from specific details of their action and location. Firstly, they degrade β-lactam antibiotic molecules, which detoxifies the environment for neighbouring cells as well as self, and secondly, they can act extracellularly, increasing the spatial range of this detoxifying effect and the benefit to neighbouring cells. Non-producer cells are able to take advantage of cross-protection from their cooperative neighbours and cooperator-cheat dynamics can emerge. However, mechanistic and ecological details determine the extent to which β-lactamase evolves as a result of its social action, or from private benefits to the producing cell. In the present review, we highlight recent work that reveals substantial variation in the extent to which β-lactamase-mediated resistance is shared among cells, focusing on subcellular localisation, membrane anchoring, outer-membrane vesicles, and population structure. We argue that β-lactamase spans a continuum from private to cooperative, and that recognising this variation is important both for understanding the evolution of antimicrobial resistance and for predicting treatment outcomes.

Indexed as

Bacteriabeta-LactamasesDrug Resistance, BacterialAnti-Bacterial Agentsbeta Lactam AntibioticsHumansAnti-Bacterial Agentsbeta Lactam Antibioticsbeta-Lactamasesantibiotic resistancecooperationsocial microbiologyβ-lactamase

Identifiers

PMID42083742
PMCPMC13538127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.